Back to Search
Start Over
P4–408: Reduced sample size for preclinical amyloid‐lowering therapeutic studies using optimal sampling of quantitative IHC data
P4–408: Reduced sample size for preclinical amyloid‐lowering therapeutic studies using optimal sampling of quantitative IHC data
- Source :
- Alzheimer's & Dementia. 9
- Publication Year :
- 2013
- Publisher :
- Wiley, 2013.
- Subjects :
- Oncology
medicine.medical_specialty
Optimal sampling
Amyloid
Epidemiology
business.industry
Health Policy
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Sample size determination
Internal medicine
Medicine
Immunohistochemistry
Neurology (clinical)
Geriatrics and Gerontology
business
Subjects
Details
- ISSN :
- 15525279 and 15525260
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Alzheimer's & Dementia
- Accession number :
- edsair.doi...........c1f785cbc640addcb81c9de1ef59bf55
- Full Text :
- https://doi.org/10.1016/j.jalz.2013.08.241